Progression to BP in all MPN subtypes has been associated with TP53 mutations and/or loss: such genetic alterations are recorded in up to 35% of patients at transformation, especially in BP occurring in advanced MPN [88,89]. The gene discussed is TP53; the disease is myeloproliferative neoplasm.